Effect of 17-α-Ethynylestradiol on Activities of Cytochrome P450 2B (P450 2B) Enzymes: Characterization of Inactivation of P450s 2B1 and 2B6 and Identification of Metabolites
- 1 February 2002
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 300 (2) , 549-558
- https://doi.org/10.1124/jpet.300.2.549
Abstract
17-α-Ethynylestradiol (17EE) inactivated purified, reconstituted rat hepatic cytochrome P450 (P450) 2B1 and human P450 2B6 in a mechanism-based manner. Little or no inactivation was observed when P450s 2B2 or 2B4 were incubated with 17EE. The inactivation of P450s 2B1 and 2B6 was entirely dependent on both NADPH and 17EE and followed pseudo-first order kinetics. The maximal rate constants for the inactivation of P450s 2B1 and 2B6 at 30°C were 0.2 and 0.03 min−1, respectively. For P450s 2B1 and 2B6 the apparentKI was 11 and 0.8 μM, respectively. Incubation of P450 2B1 with 17EE and NADPH for 20 min resulted in a 75% loss in enzymatic activity and a concurrent 20 to 25% loss of the enzyme9s ability to form a reduced CO complex. With P450 2B6, an 83% loss in enzymatic activity and a 5 to 10% loss in the CO reduced spectrum were observed. The extrapolated partition ratios for 17EE with P450 2B1 and 2B6 were 21 and 13, respectively. Simultaneous incubation of an alternate substrate together with 17EE protected both enzymes from inactivation. A 1.3:1 stoichiometry of labeling for binding of the radiolabeled 17EE to P450 2B1 and 2B6 was seen. These results indicate that 17EE inactivates P450s 2B1 and 2B6 in a mechanism-based manner, primarily by the binding of a reactive intermediate of 17EE to the apoprotein. Analysis of the 17EE metabolites showed that 2B enzymes that become inactivated differ primarily by their ability to generate two metabolites that were not produced by P450s 2B2 or 2B4.Keywords
This publication has 32 references indexed in Scilit:
- Expression of Human Cytochrome P450 2B6 in Escherichia coli: Characterization of Catalytic Activity and Expression Levels in Human LiverArchives of Biochemistry and Biophysics, 2000
- Characterization of Cytochrome P450 Enzymes in Human Breast Tissue from Reduction MammaplastiesJournal of Clinical Endocrinology & Metabolism, 1998
- Role of the Alanine at Position 363 of Cytochrome P450 2B2 in Influencing the NADPH- and Hydroperoxide-Supported ActivitiesArchives of Biochemistry and Biophysics, 1998
- Molecular Basis for the Differences in Lidocaine Binding and Regioselectivity of Oxidation by Cytochromes P450 2B1 and 2B2Biochemistry, 1998
- Identification of the Heme Adduct and an Active Site Peptide Modified during Mechanism-Based Inactivation of Rat Liver Cytochrome P450 2B1 by SecobarbitalChemical Research in Toxicology, 1996
- Structural Basis of Selective Cytochrome P450 InhibitionAnnual Review of Pharmacology and Toxicology, 1995
- A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man: Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarinBiochemical Pharmacology, 1993
- Metabolism of 17 α-ethynylestradiol in humansLife Sciences, 1990
- [10] Two forms of liver microsomal cytochrome P-450, P-450lm2 and P-450lm4 (rabbit liver)Published by Elsevier ,1978
- Neue per os-wirksame weibliche Keimdrüsenhormon-Derivate: 17-Aethinyl-oestradiol und Pregnen-in-on-3-ol-17The Science of Nature, 1938